SKN delivers hundreds of thousands of litres of its Covid-killing, plant-based, TGA-backed ‘SuprCuvr’ as latest deal pays off
Health & Biotech
Health & Biotech
Link copied to
Skin Elements’ distribution deal with Pacific Health Care is off to a massive start with strong sales and stronger demand for its TGA-backed Covid-19 disinfectant.
Australian natural health care company Skin Elements Limited (ASX: SKN) has delivered 120,000 litres of its lead disinfectant product SuprCuvr, found to be effective against COVID-19, in its first major sales order with Pacific Health Care.
Skin Elements executed a binding Agreement with medical distributor Pacific Health for the exclusive distribution of TGA registered SuprCuvr in Australia and New Zealand in January.
Skin Elements has delivered 120,200 litres of SuprCuvr in 86,040 units of various sizes, invoicing more than $1,14 million in sales for the period since the agreement was signed up to March 11.
Via the Pacific Health Agreement, SuprCuvr is now stocked by 168 IGA and 15 Good Grocer IGA supermarkets throughout Western Australia.
In addition to the retail sector, Pacific Health is supplying and marketing SuprCuvr to the mining, hospitality (including Airbnb), education, health care (hospitals and aged care), office and transport sectors.
The initial sales leaves Skin Elements and Pacific Health well placed to achieve the minimum sales volumes in the initial 12 months of its distribution agreement of 1.2 million litres of SuprCuvr.
Pacific Health Care was established in 1987 and has a successful track record of selling and distributing a range of consumable medical products into the Australian medical industry.
The private company’s customers include state governments , hospitals, aged care facilities, general practitioners and dental clinics, surgical and medical sub-distributors, veterinary clinics, and at home patients.
Skin Elements’ Executive Chairman Mr Peter Malone said the company was delighted to report initial sales results from our SuprCuvr distribution agreement with Pacific Health Care.
“Pacific Health have shown themselves to be a great partner for Skin Elements and SuprCuvr to date,” Malone said.
“Their ability to understand the product and its market, and mobilise its sales team to deliver such positive sales results and in such a short period of time is testament to their expertise, and more importantly the quality of the SuprCuvr product.”
The registration was crucial to the commercialisation of SuprCuvr for use in hospitals and aged-care homes — places that are restricted to using only TGA registered disinfectants.
The disinfectant is made from a 100% plant-based formula with independent laboratory tests confirming that SuprCuvr has 99.99999% effectiveness against COVID 192.
Skin Elements’ research indicates that SuprCuvr is the first and only approved disinfectant globally with a 99.99999% efficacy against COVID 19.
The company sees the combination of high efficacy in a 100% plant-based formula as a significant market opportunity.
This article was developed in collaboration with Skin Elements, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.